UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$463M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$360M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$345M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$265M |
| 5 |
ConocoPhillips
COP
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$293M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$239M |
| 5 |
UnitedHealth
UNH
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.86% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSII
2176
DELISTED
Cardiovascular Systems, Inc.
CSII
| $638K | ﹤0.01% |
45,998
+2,475
| +6% | +$36.8K |
|
2177
Nicolet Bankshares
NIC
$3.62B
| $637K | ﹤0.01% |
9,049
+1,365
| +18% | +$105K |
|
|
CVGW
2178
DELISTED
Calavo Growers
CVGW
| $637K | ﹤0.01% |
20,065
+2,052
| +11% | +$82.4K |
|
2179
DocGo
DCGO
$62.6M
| $636K | ﹤0.01% |
64,072
-3,528
| -5% | -$31.9K |
|
|
CTEV
2180
Claritev Corp
CTEV
$556M
| $636K | ﹤0.01% |
5,555
-1,406
| -20% | -$233K |
|
2181
uniQure
QURE
$3.22B
| $635K | ﹤0.01% |
33,853
+5,533
| +20% | +$116K |
|
2182
Caribou Biosciences
CRBU
$164M
| $634K | ﹤0.01% |
60,064
-1,954
| -3% | -$18.2K |
|
|
VGR
2183
DELISTED
Vector Group Ltd.
VGR
| $632K | ﹤0.01% |
71,732
-30,518
| -30% | -$310K |
|
2184
Opko Health
OPK
$1.02B
| $631K | ﹤0.01% |
334,071
-116,125
| -26% | -$275K |
|
|
PLYM
2185
DELISTED
Plymouth Industrial REIT
PLYM
| $630K | ﹤0.01% |
37,457
+2,319
| +7% | +$44.9K |
|
2186
John B. Sanfilippo & Son
JBSS
$972M
| $628K | ﹤0.01% |
8,292
+1,727
| +26% | +$131K |
|
|
CHS
2187
DELISTED
Chicos FAS, Inc.
CHS
| $628K | ﹤0.01% |
129,725
+24,279
| +23% | +$135K |
|
|
RADI
2188
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $628K | ﹤0.01% |
66,642
-417
| -0.6% | -$5.84K |
|
2189
Kura Oncology
KURA
$850M
| $627K | ﹤0.01% |
45,919
-294,543
| -87% | -$4.54M |
|
2190
Wipro
WIT
$20B
| $625K | ﹤0.01% |
265,242
| – | – |
|
2191
Rocket Pharmaceuticals
RCKT
$394M
| $625K | ﹤0.01% |
39,138
| – | – |
|
2192
Bionano Genomics
BNGO
$13.3M
| $624K | ﹤0.01% |
568
+1
| +0.2% | +$1.32K |
|
2193
IonQ
IONQ
$16.6B
| $624K | ﹤0.01% |
123,014
-11,199
| -8% | -$62.1K |
|
2194
Consensus Cloud Solutions
CCSI
$647M
| $623K | ﹤0.01% |
13,179
-989
| -7% | -$50.9K |
|
2195
8x8 Inc
EGHT
$332M
| $622K | ﹤0.01% |
180,285
+3,343
| +2% | +$16K |
|
|
BIG
2196
DELISTED
Big Lots, Inc.
BIG
| $622K | ﹤0.01% |
39,826
-2,665
| -6% | -$57.3K |
|
2197
Dutch Bros
BROS
$9.26B
| $621K | ﹤0.01% |
19,927
+561
| +3% | +$21.1K |
|
|
FRG
2198
DELISTED
Franchise Group, Inc.
FRG
| $619K | ﹤0.01% |
25,473
+208
| +0.8% | +$6.83K |
|
2199
Solid Power
SLDP
$532M
| $619K | ﹤0.01% |
117,626
+18,208
| +18% | +$115K |
|
|
EFC
2200
Ellington Financial
EFC
$1.71B
| $619K | ﹤0.01% |
54,414
-26,148
| -32% | -$390K |
|
Similar funds
UBS AM's Q3 2022 Portfolio in Review
As of Q3 2022, UBS AM held 2,816 positions worth $178B, down 6.6% from $191B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM's Q3 2022 filing shows 65 new, 702 increased, 1,679 reduced and 77 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M. The largest sale was Apple, an estimated $2.03B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q3 2022 buy was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M.
- UBS AM added most to Accenture in Q3 2022, an estimated $463M increase.
- UBS AM's biggest Q3 2022 reduction was Apple, cutting an estimated $2.03B.
- UBS AM fully exited Vanguard Russell 1000 ETF in Q3 2022, selling an estimated $93.3M.
- UBS AM's ten largest holdings make up 21% of its $178B portfolio in Q3 2022.
- UBS AM opened 65 new positions and closed 77 in Q3 2022.
- UBS AM's portfolio value fell 6.6% quarter-over-quarter to $178B.
Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.